BLASTS MORE THAN 5 PERCENT OF PERIPHERAL BLOOD WHITE CELLS

Clinical trials for BLASTS MORE THAN 5 PERCENT OF PERIPHERAL BLOOD WHITE CELLS explained in plain language.

Never miss a new study

Get alerted when new BLASTS MORE THAN 5 PERCENT OF PERIPHERAL BLOOD WHITE CELLS trials appear

Sign up with your email to follow new studies for BLASTS MORE THAN 5 PERCENT OF PERIPHERAL BLOOD WHITE CELLS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for patients with rare, Hard-to-Treat blood disorders

Disease control Recruiting now

This study is testing whether the drug ruxolitinib can help control rare blood disorders where the body makes too many eosinophils, a type of white blood cell. It will involve about 10 adults whose conditions have not responded well to standard treatments like steroids. The main …

Matched conditions: BLASTS MORE THAN 5 PERCENT OF PERIPHERAL BLOOD WHITE CELLS

Phase: PHASE2 • Sponsor: William Shomali • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

BLASTS MORE THAN 5 PERCENT OF PERIPHERAL BLOOD WHITE CELLS

Get alerted when new BLASTS MORE THAN 5 PERCENT OF PERIPHERAL BLOOD WHITE CELLS trials appear

New hope for patients with rare, Hard-to-Treat blood disorders